Matthew A. Spear

Matthew A. Spear

57 year
Health Technology
Consumer Services
Commercial Services

Profile

Matthew A.
Spear
worked as Vice President-Clinical Development at Incyte Corp.
from 2014 to 2016, Head-Oncology & Biotherapeutics at Sumitomo Pharma America, Inc. from 2012 to 2014, and Chief Medical Officer & Senior Vice President at Nereus Pharmaceuticals, Inc. from 2005 to 2011.
He also worked as an Associate Professor at UC San Diego School of Medicine and Keck School of Medicine of USC.
He is currently the Chief Medical Officer at Poseida Therapeutics, Inc. Dr. Spear received his doctorate from Stanford University and his undergraduate degree from The Johns Hopkins University.

Former positions of Matthew A. Spear

CompaniesPositionEnd
POSEIDA THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 21/04/2022
SANGAMO THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 30/06/2016
INCYTE CORPORATION Corporate Officer/Principal 31/12/2015
Corporate Officer/Principal 30/06/2014
Chief Tech/Sci/R&D Officer 31/12/2010
See the detail of Matthew A. Spear's experience

Training of Matthew A. Spear

The Johns Hopkins University Undergraduate Degree
Stanford University Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Matthew A. Spear's experience

Connections

61

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies4
PFIZER, INC.

Health Technology

SANGAMO THERAPEUTICS, INC.

Health Technology

POSEIDA THERAPEUTICS, INC.

Health Technology

INCYTE CORPORATION

Health Technology

Private companies4

Commercial Services

Government

Miscellaneous

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Matthew A. Spear